Kisucka Janka, Butterfield Catherine E, Duda Dan G, Eichenberger Sarah C, Saffaripour Simin, Ware Jerry, Ruggeri Zaverio M, Jain Rakesh K, Folkman Judah, Wagner Denisa D
CBR Institute for Biomedical Research, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60. doi: 10.1073/pnas.0510412103. Epub 2006 Jan 17.
Platelets contain both pro- and antiangiogenic factors, but their regulatory role in angiogenesis is poorly understood. Although previous studies showed that platelets stimulate angiogenesis in vitro, the role of platelets in angiogenesis in vivo is largely uncharacterized. To address this topic, we used two in vivo approaches, the cornea micropocket assay and the Matrigel model, in four animal models: thrombocytopenic, Lyst(bg) (platelet storage pool deficiency), glycoprotein (GP) Ibalpha/IL4R transgenic (lacking extracellular GPIbalpha, the receptor for von Willebrand factor as well as other adhesive and procoagulant proteins), and FcgammaR(-/-) (lacking functional GPVI, the collagen receptor) mice. Adult mice were rendered thrombocytopenic by i.p. administration of an antiplatelet antibody. The number of growing vessels in the thrombocytopenic mice was lower in the cornea assay, and they showed significantly increased appearance of hemorrhage compared with mice treated with control IgG. The thrombocytopenic mice also showed more protein leakage and developed hematomas in the Matrigel model. GPIbalpha/IL4R transgenic mice presented increased hemorrhage in both assays, but it was less severe than in the platelet-depleted mice. FcgammaR(-/-) and Lyst(bg) mice showed no defect in experimental angiogenesis. Intravital microscopy revealed a >3-fold increase in platelet adhesion to angiogenic vessels of Matrigel compared with mature quiescent skin vessels. Our results suggest that the presence of platelets not only stimulates angiogenic vessel growth but also plays a critical role in preventing hemorrhage from the angiogenic vessels. The adhesion function of platelets, as mediated by GPIbalpha, significantly contributes to the process.
血小板同时含有促血管生成因子和抗血管生成因子,但其在血管生成中的调节作用却鲜为人知。尽管先前的研究表明血小板在体外可刺激血管生成,但血小板在体内血管生成中的作用在很大程度上仍未得到充分表征。为了解决这个问题,我们在四种动物模型中采用了两种体内方法,即角膜微袋试验和基质胶模型:血小板减少症模型、Lyst(bg)(血小板储存池缺陷)模型、糖蛋白(GP)Ibalpha/IL4R转基因(缺乏细胞外GPIbalpha,血管性血友病因子以及其他黏附蛋白和促凝蛋白的受体)模型和FcgammaR(-/-)(缺乏功能性GPVI,胶原蛋白受体)小鼠模型。通过腹腔注射抗血小板抗体使成年小鼠出现血小板减少症。在角膜试验中,血小板减少症小鼠中生长血管的数量较少,并且与用对照IgG处理的小鼠相比,它们出现出血的情况明显增加。在基质胶模型中,血小板减少症小鼠还表现出更多的蛋白渗漏并形成血肿。GPIbalpha/IL4R转基因小鼠在两种试验中均出现出血增加,但程度不如血小板减少的小鼠严重。FcgammaR(-/-)和Lyst(bg)小鼠在实验性血管生成方面未显示出缺陷。活体显微镜检查显示,与成熟的静止皮肤血管相比,基质胶中血管生成血管上的血小板黏附增加了3倍以上。我们的结果表明,血小板的存在不仅刺激血管生成血管的生长,而且在防止血管生成血管出血方面也起着关键作用。由GPIbalpha介导的血小板黏附功能对这一过程有显著贡献。